A Comprehensive Study on Adverse Drug Reactions (ADRs) and Their Monitoring Approaches

Abstract

This investigation utilizes a Knowledge Assessment Questionnaire (KAQ) to gauge patients' understanding of their health issues and to spot possible Adverse Drug Reactions (ADRs). On a global scale, ADRs are among the top factors driving illness and death rates, while also raising healthcare expenses considerably. The goals here include: (a) assessing how common ADRs are in hospital settings via proactive tracking, and (b) examining the nature and medical features of these responses.The review further assesses the existing pharmacovigilance systems for identifying and overseeing ADRs. It outlines the functional setup, advantages, drawbacks, and key elements of India's ADR surveillance mechanism. The Central Drugs Standard Control Organization (CDSCO) manages the safety, standards, and effectiveness of drugs via over 200 Adverse Drug Reaction Monitoring Centres (AMCs) nationwide. As part of the Pharmacovigilance Programme of India (PvPI), these units must submit ADR information to the National Coordination Centre (NCC) at the Indian Pharmacopoeia Commission (IPC) in Ghaziabad. Medical experts and everyday people can notify the NCC of potential ADRs through a uniform, multi-language form aimed at promoting ease and broad participation.